The Food and Drug Administration announced on Monday it has given full approval for a new preventative injection for infants under age 2 to protect them from contracting respiratory syncytial virus, ...

A Public Health Alerts report today details successful administration of intramuscular immunoglobulin (IMIG) as post-exposure ...

The safety of the monoclonal antibody nirsevimab and the effect of nirsevimab on hospitalizations for respiratory syncytial virus (RSV)–associated lower respiratory tract infection when administered ...

After a large-scale exposure, health department developed a protocol for statewide use ...